tiprankstipranks
Trending News
More News >
Biotage AB (BITGF)
OTHER OTC:BITGF
US Market

Biotage AB (BITGF) Stock Forecast & Price Target

Compare
8 Followers
See the Price Targets and Ratings of:

BITGF Financial Forecast

BITGF Earnings Forecast

Next quarter’s earnings estimate for BITGF is $0.07 with a range of $0.04 to $0.11. The previous quarter’s EPS was $0.07. BITGF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year BITGF has Outperformed its overall industry.
Next quarter’s earnings estimate for BITGF is $0.07 with a range of $0.04 to $0.11. The previous quarter’s EPS was $0.07. BITGF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year BITGF has Outperformed its overall industry.

BITGF Sales Forecast

Next quarter’s sales forecast for BITGF is $48.47M with a range of $41.35M to $52.87M. The previous quarter’s sales results were $40.40M. BITGF beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year BITGF has Outperformed its overall industry.
Next quarter’s sales forecast for BITGF is $48.47M with a range of $41.35M to $52.87M. The previous quarter’s sales results were $40.40M. BITGF beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year BITGF has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on BITGF
Unknown AnalystDanske Bank
Not Ranked
Danske Bank
$14.81
Hold
-1.55%
Downside
Downgraded
04/23/25
Biotage downgraded to Hold from Buy at Danske BankBiotage downgraded to Hold from Buy at Danske Bank
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on BITGF
Unknown AnalystDanske Bank
Not Ranked
Danske Bank
$14.81
Hold
-1.55%
Downside
Downgraded
04/23/25
Biotage downgraded to Hold from Buy at Danske BankBiotage downgraded to Hold from Buy at Danske Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biotage AB

1 Month
xxx
Success Rate
6/8 ratings generated profit
75%
Average Return
+11.91%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +11.91% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+9.04%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +9.04% per trade.
1 Year
Odysseas ManesiotisExane BNP Paribas
Success Rate
4/8 ratings generated profit
50%
Average Return
+5.74%
reiterated a buy rating a year ago
Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.74% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
-8.40%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -8.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BITGF Analyst Recommendation Trends

Rating
May 23
Jun 23
Sep 23
Oct 23
Jan 24
Strong Buy
3
2
3
4
4
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
3
4
4
In the current month, BITGF has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BITGF average Analyst price target in the past 3 months is 14.81.
Each month's total comprises the sum of three months' worth of ratings.

BITGF Stock Forecast FAQ

What is BITGF’s average 12-month price target, according to analysts?
Based on analyst ratings, Biotage AB’s 12-month average price target is 14.81.
    What is BITGF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for BITGF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is BITGF a Buy, Sell or Hold?
        Biotage AB has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Biotage AB’s price target?
          The average price target for Biotage AB is 14.81. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $14.81 ,the lowest forecast is $14.81. The average price target represents -1.53% Decrease from the current price of $15.04.
            What do analysts say about Biotage AB?
            Biotage AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of BITGF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis